SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Oncternal Therapeutics Q1 EPS $(0.310)

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(0.310) per share.

Benzinga · 05/07/2020 12:35

Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(0.310) per share.